Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
23:05
The only anti-war party in Russia has been excluded from the electoral race.
23:00
Over 1,200 Palestinians have been killed in Gaza since the ceasefire with Israel came into effect in October 2025. UN experts warn of the ongoing genocide.
22:55
The Alba Iulia Court of Appeal rejected the proposal for the preventive arrest of prosecutor Radu George Bucurică, accused of crimes related to the illegal possession and use of a lethal firearm.
22:53
Diana Buzoianu announced that the estimates for the operation of Unit 2 at Cernavodă have been revised negatively: "We are in a much gloomier forecast than we were yesterday."
22:47
Ionel Bogdan (PNL) accuses disinformation on TikTok for the attack on an ambulance and requests the hearing of the president of ANCOM in Parliament.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
